Evidence map›Paper›PMID 27592711›Full record

ArticleEuropean journal of immunology2016

IL-33 delivery induces serous cavity macrophage proliferation independent of interleukin-4 receptor alpha.

Lucy H Jackson-Jones, Dominik Rückerl, Freya Svedberg, Sheelagh Duncan, Rick M Maizels, Tara E Sutherland, Stephen J Jenkins, Henry J McSorley, Cécile Bénézech, Andrew S MacDonald and 1 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Enhanced Proliferation of Ly6CJournal of immunology (Baltimore, Md. : 1950) · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Lucy H Jackson-JonesSchool of Biological Sciences, University of Edinburgh, Edinburgh, EH9 3FL, UK.
Dominik RückerlSchool of Biological Sciences, University of Edinburgh, Edinburgh, EH9 3FL, UK.
Freya SvedbergFaculty of Biology, Medicine & Health, University of Manchester, Manchester, M13 9PT, UK.
Sheelagh DuncanSchool of Biological Sciences, University of Edinburgh, Edinburgh, EH9 3FL, UK.
Rick M MaizelsInstitute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, G12 8TA, UK.
Tara E SutherlandSchool of Biological Sciences, University of Edinburgh, Edinburgh, EH9 3FL, UK.
Stephen J JenkinsCentre for Inflammation Research, University of Edinburgh, Edinburgh, EH16 4TJ, UK.
Henry J McSorleySchool of Biological Sciences, University of Edinburgh, Edinburgh, EH9 3FL, UK.
Cécile BénézechCentre for Cardiovascular Science, University of Edinburgh, Edinburgh, EH16 4TJ, UK.
Andrew S MacDonaldFaculty of Biology, Medicine & Health, University of Manchester, Manchester, M13 9PT, UK.
Judith E AllenSchool of Biological Sciences, University of Edinburgh, Edinburgh, EH9 3FL, UK. judi.allen@manchester.ac.uk.
University of Edinburgh · GBUniversity of Manchester · GBUniversity of Glasgow · GB

Funding

Medical Research Council MR/J001929/1Medical Research Council MR/K01207X/1Medical Research Council MR/K01207X/2Medical Research Council MR/M011542/1
6 · The paper itself

Abstract

IL-33 plays an important role in the initiation of type-2 immune responses, as well as the enhancement of type 2 effector functions. Engagement of the IL-33 receptor on macrophages facilitates polarization to an alternative activation state by amplifying IL-4 and IL-13 signaling to IL-4Rα. IL-4 and IL-13 also induce macrophage proliferation but IL-33 involvement in this process has not been rigorously evaluated. As expected, in vivo delivery of IL-33 induced IL-4Rα-dependent alternative macrophage activation in the serous cavities. IL-33 delivery also induced macrophages to proliferate but, unexpectedly, this was independent of IL-4Rα signaling. In a filarial nematode infection model in which IL-4Rα-dependent alternative activation and proliferation in the pleural cavity is well described, IL-33R was essential for alternative activation but not macrophage proliferation. Similarly, during Alternaria alternata induced airway inflammation, which provokes strong IL-33 responses, we observed that both IL-4Rα and IL-33R were required for alternative activation, while macrophage proliferation in the pleural cavity was still evident in the absence of either receptor alone. Our data show that IL-33R and IL-4Rα promote macrophage proliferation independently of each other, but both are essential for induction of alternative activation.

Indexed as

AlternariaAlternariosisAnimalsCell ProliferationCells, CulturedFilariasisFilarioideaInterleukin-1 Receptor-Like 1 ProteinInterleukin-33Interleukin-4 Receptor alpha SubunitMacrophage ActivationMacrophagesMiceMice, Inbred BALB CMice, KnockoutPleural CavityIl4ra protein, mouseInterleukin-1 Receptor-Like 1 ProteinInterleukin-33Interleukin-4 Receptor alpha SubunitReceptors, Cell SurfaceAlternariaIL-33IL-4MacrophageNematodeProliferation

Identifiers

PMID27592711
PMCPMC5082546
OpenAlexW2516220433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.